Informed Consent Action Network v. FDA (D.D.C.) -- granting 18-month stay after finding that FDA’s Center for Biologics Evaluation and Research (CBER) faced exceptional circumstances, specifically “skyrocketing” requests since 2019 and litigation rates that had “exploded” in same time period; noting that agency had demonstrated due diligence through staff reallocation, new hires, and a tiered response system; further noting that plaintiff was a “major contributor to the onslaught,” having submitted more than 350 FOIA requests to CBER and accounting for two-thirds of CBER's open FOIA lawsuits.
Summaries of all published opinions issued in 2025 are available here. Earlier opinions are available for 2024 and from 2015 to 2023.